Index - P/E - EPS (ttm) -3.30 Insider Own 11.27% Shs Outstand 69.02M Perf Week -6.65%
Market Cap 804.77M Forward P/E - EPS next Y -3.55 Insider Trans 22.61% Shs Float 61.24M Perf Month -11.67%
Income -167.25M PEG - EPS next Q -0.86 Inst Own 53.58% Short Float 7.02% Perf Quarter -43.01%
Sales 36.97M P/S 21.77 EPS this Y 40.58% Inst Trans 6.76% Short Ratio 8.13 Perf Half Y -48.79%
Book/sh 12.04 P/B 0.97 EPS next Y -17.67% ROA -20.45% Short Interest 4.30M Perf Year -48.61%
Cash/sh 12.91 P/C 0.90 EPS next 5Y 6.06% ROE -26.82% 52W Range 11.14 - 28.67 Perf YTD -16.71%
Dividend Est. - P/FCF - EPS past 5Y -12.36% ROI -19.99% 52W High -59.33% Beta 1.09
Dividend TTM - Quick Ratio 17.13 Sales past 5Y 24.55% Gross Margin 80.63% 52W Low 4.67% ATR (14) 0.77
Dividend Ex-Date - Current Ratio 17.13 EPS Y/Y TTM 33.96% Oper. Margin -635.58% RSI (14) 34.59 Volatility 5.40% 5.61%
Employees 284 Debt/Eq 0.01 Sales Y/Y TTM 48.46% Profit Margin -452.39% Recom 1.47 Target Price 32.00
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q 40.65% Payout - Rel Volume 0.92 Prev Close 12.00
Sales Surprise -60.76% EPS Surprise 7.11% Sales Q/Q -49.19% Earnings Oct 31 BMO Avg Volume 529.09K Price 11.66
SMA20 -6.89% SMA50 -17.58% SMA200 -43.71% Trades
Volume 488,864 Change -2.83%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-08-24 Initiated Stephens
Equal-Weight
$25
Sep-06-24 Initiated RBC Capital Mkts
Outperform
$35
Aug-07-24 Downgrade B. Riley Securities
Buy → Neutral
$33 → $28
Sep-11-23 Upgrade B. Riley Securities
Neutral → Buy
Aug-31-22 Initiated Cowen
Outperform
Jul-28-22 Initiated Barclays
Overweight
$30
Jul-06-22 Resumed Canaccord Genuity
Buy
$60
Apr-13-22 Downgrade B. Riley Securities
Buy → Neutral
$62 → $33
Apr-07-22 Resumed Cantor Fitzgerald
Overweight
$100 → $80
Feb-14-22 Initiated Morgan Stanley
Equal-Weight
$60
Dec-17-21 Initiated SVB Leerink
Outperform
$70
Dec-09-21 Initiated Needham
Buy
$85
Sep-30-21 Initiated B. Riley Securities
Buy
$56
Apr-20-21 Initiated JMP Securities
Mkt Outperform
$53
Oct-12-20 Initiated Cantor Fitzgerald
Overweight
$30
Jun-12-20 Initiated Oppenheimer
Outperform
Apr-17-20 Initiated H.C. Wainwright
Buy
$25
Nov-14-19 Initiated ROTH Capital
Buy
$17
Sep-11-19 Upgrade Goldman
Neutral → Buy
$14
Jun-17-19 Initiated Piper Jaffray
Overweight
$20
Show Previous Ratings
Feb-14-25 02:11PM
Feb-05-25 07:00AM
Feb-03-25 04:05PM
Jan-13-25 07:00AM
Jan-09-25 07:00AM
04:05PM
Loading…
Jan-03-25 04:05PM
Dec-20-24 03:27PM
Dec-13-24 07:50AM
Dec-12-24 06:30PM
Dec-10-24 07:00AM
Dec-02-24 04:05PM
Nov-25-24 05:30PM
Nov-13-24 10:39AM
Nov-12-24 07:00AM
Nov-01-24 04:05PM
07:00AM
Loading…
Oct-31-24 07:00AM
Oct-23-24 07:00AM
Oct-17-24 02:29PM
Oct-16-24 07:00AM
Oct-14-24 05:36AM
Oct-02-24 04:05PM
Sep-14-24 03:00AM
Sep-06-24 01:37PM
Sep-03-24 04:05PM
Aug-21-24 07:00AM
Aug-09-24 12:00PM
09:55AM
Aug-06-24 01:53PM
07:05AM
Aug-01-24 04:05PM
07:00AM
Loading…
Jul-22-24 07:00AM
Jun-27-24 09:40AM
Jun-11-24 09:40AM
Jun-03-24 07:00AM
May-24-24 12:25PM
09:55AM
May-23-24 05:05PM
07:00AM
May-21-24 09:40AM
May-16-24 05:23PM
May-06-24 12:00PM
09:55AM
May-02-24 01:54PM
08:44AM
07:00AM
Apr-24-24 10:05AM
Apr-02-24 07:00AM
Mar-05-24 04:35PM
Feb-28-24 07:00AM
Feb-20-24 07:05AM
Feb-07-24 07:00AM
Jan-22-24 10:54AM
Jan-05-24 02:02AM
Dec-14-23 07:00AM
Nov-30-23 07:00AM
Nov-02-23 08:46AM
07:00AM
06:04AM
Oct-30-23 07:00AM
Oct-19-23 07:00AM
04:00AM
Sep-14-23 10:12AM
Sep-12-23 07:54AM
06:36AM
Sep-11-23 02:19PM
07:00AM
Sep-05-23 07:00AM
Aug-03-23 06:59AM
Jul-18-23 07:00AM
06:45AM
Jul-14-23 06:47AM
Jul-13-23 06:40PM
Jul-12-23 10:23PM
04:01PM
Jun-23-23 07:30AM
Jun-13-23 07:00AM
May-31-23 07:00AM
May-14-23 08:05AM
May-11-23 06:59AM
May-10-23 08:00AM
07:29AM
May-04-23 09:55AM
07:00AM
06:45AM
Apr-14-23 07:00AM
Apr-03-23 07:00AM
Mar-31-23 06:36AM
Mar-29-23 08:17AM
Mar-28-23 07:00AM
Feb-28-23 09:00AM
07:00AM
Feb-14-23 06:59AM
Feb-08-23 07:00AM
Jan-29-23 09:46AM
Jan-11-23 07:00AM
Jan-04-23 07:00AM
Nov-10-22 09:09AM
Nov-09-22 08:03AM
Nov-08-22 07:00AM
05:03AM
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Thompson Travis Alvin CHIEF ACCOUNTING OFFICER Jan 06 '25 Sale 15.00 2,686 40,290 32,146 Jan 06 07:30 PM Thompson Travis Alvin CHIEF ACCOUNTING OFFICER Jan 02 '25 Sale 14.09 1,750 24,658 34,991 Jan 06 07:30 PM Thompson Travis Alvin CHIEF ACCOUNTING OFFICER Jan 03 '25 Sale 14.75 159 2,345 34,832 Jan 06 07:30 PM Young Alethia Chief Financial Officer Jan 02 '25 Sale 14.09 1,395 19,656 45,605 Jan 06 07:30 PM Arroyo Santiago CHIEF DEVELOPMENT OFFICER Jan 02 '25 Sale 14.09 4,943 69,647 69,057 Jan 06 07:30 PM Crockett Nigel CHIEF BUSINESS OFFICER Jan 02 '25 Sale 14.09 2,583 36,394 51,989 Jan 06 07:30 PM Crockett Nigel CHIEF BUSINESS OFFICER Jan 03 '25 Sale 14.75 936 13,806 51,053 Jan 06 07:30 PM Milnes Alistair CHIEF OPERATING OFFICER Jan 02 '25 Sale 14.09 4,578 64,504 100,724 Jan 06 07:30 PM Milnes Alistair CHIEF OPERATING OFFICER Jan 03 '25 Sale 14.75 936 13,806 99,788 Jan 06 07:30 PM Skynner Michael CHIEF TECHNOLOGY OFFICER Jan 02 '25 Sale 14.09 3,287 46,314 124,658 Jan 06 07:30 PM Skynner Michael CHIEF TECHNOLOGY OFFICER Jan 03 '25 Sale 14.75 936 13,806 123,722 Jan 06 07:30 PM Hannay Michael Charles Ferguso CHIEF PROD & SUPPLY CHAIN OFF Jan 02 '25 Sale 14.09 1,879 26,475 55,519 Jan 06 07:30 PM Hannay Michael Charles Ferguso CHIEF PROD & SUPPLY CHAIN OFF Jan 03 '25 Sale 14.75 239 3,525 55,280 Jan 06 07:30 PM Lee Kevin CHIEF EXECUTIVE OFFICER Jan 02 '25 Sale 14.09 9,038 127,345 495,026 Jan 06 07:30 PM Lee Kevin CHIEF EXECUTIVE OFFICER Jan 03 '25 Sale 14.75 3,092 45,607 491,934 Jan 06 07:30 PM Thompson Travis Alvin Officer Jan 06 '25 Proposed Sale 15.00 2,686 40,290 Jan 06 12:06 PM Thompson Travis Alvin Officer Jan 02 '25 Proposed Sale 14.00 2,016 28,224 Jan 02 04:22 PM Young Alethia Officer Jan 02 '25 Proposed Sale 14.00 1,395 19,530 Jan 02 04:21 PM Arroyo Santiago Officer Jan 02 '25 Proposed Sale 14.00 4,943 69,202 Jan 02 04:20 PM Hannay Michael Charles Ferguso Officer Jan 02 '25 Proposed Sale 14.00 2,145 30,030 Jan 02 04:18 PM Crockett Nigel Officer Jan 02 '25 Proposed Sale 14.00 3,636 50,904 Jan 02 04:17 PM Milnes Alistair Officer Jan 02 '25 Proposed Sale 14.00 5,631 78,834 Jan 02 04:16 PM Skynner Michael Officer Jan 02 '25 Proposed Sale 14.00 4,340 60,760 Jan 02 04:15 PM Lee Kevin Officer Jan 02 '25 Proposed Sale 14.00 12,516 175,224 Jan 02 04:14 PM BAKER BROS. ADVISORS LP Director Dec 13 '24 Buy 13.76 985,397 13,559,485 9,537,643 Dec 17 06:03 PM BAKER BROS. ADVISORS LP Director Dec 16 '24 Buy 15.34 500,000 7,670,900 9,995,274 Dec 17 06:03 PM Thompson Travis Alvin CHIEF ACCOUNTING OFFICER Nov 11 '24 Option Exercise 5.67 2,575 14,608 24,234 Nov 13 07:43 PM Thompson Travis Alvin CHIEF ACCOUNTING OFFICER Nov 11 '24 Sale 25.11 6,256 157,114 19,241 Nov 13 07:43 PM Thompson Travis Alvin Officer Nov 11 '24 Proposed Sale 25.11 6,256 157,112 Nov 12 09:00 AM Lee Kevin CHIEF EXECUTIVE OFFICER Oct 03 '24 Sale 22.26 3,212 71,499 380,864 Oct 04 04:50 PM Hannay Michael Charles Ferguso CHIEF PROD & SUPPLY CHAIN OFF Oct 03 '24 Sale 22.26 247 5,498 22,398 Oct 04 04:50 PM Skynner Michael CHIEF TECHNOLOGY OFFICER Oct 03 '24 Sale 22.26 972 21,637 92,945 Oct 04 04:50 PM Milnes Alistair CHIEF OPERATING OFFICER Oct 03 '24 Sale 22.26 972 21,637 70,302 Oct 04 04:50 PM Crockett Nigel CHIEF BUSINESS OFFICER Oct 03 '24 Sale 22.26 972 21,637 45,822 Oct 04 04:50 PM Thompson Travis Alvin CHIEF ACCOUNTING OFFICER Oct 03 '24 Sale 22.26 153 3,406 22,922 Oct 04 04:50 PM Thompson Travis Alvin Officer Oct 03 '24 Proposed Sale 22.56 153 3,451 Oct 03 04:30 PM Keen Nicholas Officer Oct 03 '24 Proposed Sale 22.56 308 6,948 Oct 03 04:28 PM Hannay Michael Charles Ferguso Officer Oct 03 '24 Proposed Sale 22.56 247 5,572 Oct 03 04:25 PM Crockett Nigel Officer Oct 03 '24 Proposed Sale 22.56 972 21,928 Oct 03 04:22 PM Milnes Alistair Officer Oct 03 '24 Proposed Sale 22.56 972 21,928 Oct 03 04:19 PM Skynner Michael Officer Oct 03 '24 Proposed Sale 22.56 972 21,928 Oct 03 04:17 PM Lee Kevin Officer Oct 03 '24 Proposed Sale 22.56 3,212 72,462 Oct 03 04:15 PM Hannay Michael Charles Ferguso CHIEF PROD & SUPPLY CHAIN OFF Jul 03 '24 Sale 19.64 246 4,831 22,645 Jul 08 06:57 PM Skynner Michael CHIEF TECHNOLOGY OFFICER Jul 03 '24 Sale 19.64 967 18,992 93,917 Jul 08 06:55 PM Thompson Travis Alvin CHIEF ACCOUNTING OFFICER Jul 03 '24 Sale 19.64 148 2,907 23,075 Jul 08 06:55 PM Crockett Nigel CHIEF BUSINESS OFFICER Jul 03 '24 Sale 19.64 967 18,992 46,794 Jul 08 06:55 PM Keen Nicholas CHIEF SCIENTIFIC OFFICER Jul 03 '24 Sale 19.64 779 15,300 62,024 Jul 08 06:55 PM Lee Kevin CHIEF EXECUTIVE OFFICER Jul 03 '24 Sale 19.64 3,194 62,730 384,076 Jul 08 06:55 PM Milnes Alistair CHIEF OPERATING OFFICER Jul 03 '24 Sale 19.64 967 18,992 71,274 Jul 08 06:55 PM Hannay Michael Charles Ferguso CHIEF PROD & SUPPLY CHAIN OFF Apr 11 '24 Sale 22.49 257 5,780 22,891 Apr 12 04:30 PM Lee Kevin CHIEF EXECUTIVE OFFICER Apr 03 '24 Sale 23.81 3,158 75,192 387,270 Apr 05 04:30 PM Skynner Michael CHIEF TECHNOLOGY OFFICER Apr 03 '24 Sale 23.81 955 22,739 94,884 Apr 05 04:30 PM Milnes Alistair CHIEF OPERATING OFFICER Apr 03 '24 Sale 23.81 955 22,739 72,241 Apr 05 04:30 PM Crockett Nigel CHIEF BUSINESS OFFICER Apr 03 '24 Sale 23.81 955 22,739 47,761 Apr 05 04:30 PM Keen Nicholas CHIEF SCIENTIFIC OFFICER Apr 03 '24 Sale 23.81 790 18,810 62,803 Apr 05 04:30 PM Thompson Travis Alvin CHIEF ACCOUNTING OFFICER Apr 03 '24 Sale 23.81 152 3,619 23,223 Apr 05 04:30 PM
Index RUT P/E - EPS (ttm) -5.94 Insider Own 2.68% Shs Outstand 76.95M Perf Week 2.05%
Market Cap 3.91B Forward P/E - EPS next Y -1.48 Insider Trans -11.17% Shs Float 75.08M Perf Month 12.44%
Income -453.20M PEG - EPS next Q -0.54 Inst Own 99.73% Short Float 5.54% Perf Quarter 29.21%
Sales 900.66M P/S 4.34 EPS this Y 46.79% Inst Trans -1.92% Short Ratio 5.67 Perf Half Y 47.40%
Book/sh -13.70 P/B - EPS next Y 66.68% ROA -29.22% Short Interest 4.16M Perf Year 95.11%
Cash/sh 13.14 P/C 3.86 EPS next 5Y 36.78% ROE - 52W Range 24.00 - 54.16 Perf YTD 12.30%
Dividend Est. - P/FCF - EPS past 5Y -24.94% ROI - 52W High -6.41% Beta 0.70
Dividend TTM - Quick Ratio 2.04 Sales past 5Y 32.36% Gross Margin 77.26% 52W Low 111.25% ATR (14) 2.02
Dividend Ex-Date - Current Ratio 2.10 EPS Y/Y TTM 31.43% Oper. Margin -14.18% RSI (14) 60.36 Volatility 3.97% 4.31%
Employees 995 Debt/Eq - Sales Y/Y TTM 12.84% Profit Margin -50.32% Recom 2.20 Target Price 62.64
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q 21.40% Payout - Rel Volume 0.58 Prev Close 50.38
Sales Surprise 15.36% EPS Surprise 8.61% Sales Q/Q 0.11% Earnings Feb 27 AMC Avg Volume 733.35K Price 50.69
SMA20 4.15% SMA50 8.14% SMA200 29.62% Trades
Volume 423,033 Change 0.62%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-13-24 Upgrade Morgan Stanley
Equal-Weight → Overweight
$45 → $67
Dec-03-24 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$39 → $63
Oct-10-24 Resumed Raymond James
Mkt Perform
Sep-04-24 Initiated Robert W. Baird
Outperform
$44
Aug-26-24 Resumed UBS
Buy
$47
May-20-24 Upgrade Raymond James
Underperform → Mkt Perform
Dec-19-23 Downgrade Morgan Stanley
Equal-Weight → Underweight
$28
Dec-08-23 Initiated Wells Fargo
Overweight
$37
Oct-30-23 Upgrade Oppenheimer
Perform → Outperform
$165
Oct-27-23 Downgrade Citigroup
Neutral → Sell
$29 → $17
Oct-06-23 Downgrade Truist
Buy → Hold
$45 → $25
Sep-18-23 Downgrade Citigroup
Buy → Neutral
$55 → $28
Sep-15-23 Downgrade Raymond James
Outperform → Underperform
Mar-17-23 Initiated SVB Securities
Market Perform
$48
Dec-14-22 Initiated Goldman
Sell
$35
Sep-12-22 Initiated Jefferies
Buy
$62
Sep-09-22 Initiated Morgan Stanley
Equal-Weight
$54
Sep-01-22 Initiated Citigroup
Buy
$70
Apr-04-22 Resumed Cantor Fitzgerald
Overweight
$64 → $63
Oct-18-21 Downgrade BofA Securities
Neutral → Underperform
$38
Show Previous Ratings
Feb-20-25 10:00AM
08:00AM
Feb-19-25 07:00AM
Feb-13-25 08:00AM
Feb-04-25 08:21AM
05:01AM
Loading…
05:01AM
Feb-03-25 03:07PM
Jan-13-25 04:30PM
09:00AM
09:00AM
Dec-23-24 08:00AM
Dec-19-24 08:00AM
Dec-17-24 04:30PM
Dec-10-24 05:11PM
(Investor's Business Daily)
09:34AM
(Investor's Business Daily)
07:15AM
Loading…
Dec-04-24 07:15AM
Dec-03-24 04:42AM
(Pharmaceutical Technology)
Dec-02-24 04:21PM
(Investor's Business Daily) +18.66%
12:58PM
12:40PM
11:29AM
07:00AM
05:56AM
Nov-28-24 07:11AM
Nov-27-24 10:12AM
07:51AM
07:00AM
05:38AM
Nov-26-24 04:30PM
Nov-25-24 04:30PM
01:46PM
Loading…
Nov-14-24 01:46PM
10:00AM
(Pharmaceutical Technology)
06:28AM
Nov-13-24 06:02PM
Nov-08-24 10:05AM
Nov-07-24 06:30PM
05:25PM
04:23PM
(Associated Press Finance)
04:01PM
Nov-06-24 09:15AM
07:11AM
Nov-04-24 04:30PM
Nov-01-24 06:06AM
Oct-30-24 07:00AM
Oct-25-24 04:30PM
Oct-24-24 07:00AM
Oct-18-24 03:01PM
07:04AM
06:30AM
Oct-17-24 10:01AM
Oct-14-24 04:30PM
Oct-09-24 05:54PM
03:07PM
Oct-08-24 08:00AM
Oct-04-24 05:17AM
Oct-01-24 09:00AM
05:00AM
Sep-26-24 08:00AM
Sep-12-24 04:30PM
Aug-28-24 04:30PM
Aug-19-24 03:33PM
(Investor's Business Daily)
Aug-08-24 05:15PM
04:09PM
(Associated Press Finance)
04:01PM
Aug-06-24 09:15AM
Jul-30-24 08:00AM
Jul-25-24 04:30PM
10:02AM
Jul-01-24 08:00AM
Jun-28-24 04:08PM
(Investor's Business Daily) -11.77%
08:53AM
(Investor's Business Daily)
07:49AM
06:00AM
Jun-24-24 04:44AM
Jun-21-24 04:30PM
Jun-20-24 08:19AM
06:30AM
Jun-04-24 06:00AM
May-29-24 08:00AM
May-28-24 08:30AM
May-25-24 02:41AM
May-21-24 12:26PM
10:34AM
May-20-24 04:05PM
(Investor's Business Daily) +21.23%
12:36PM
12:20PM
08:57AM
08:45AM
07:45AM
May-14-24 09:10AM
08:51AM
08:26AM
07:30AM
May-02-24 08:00AM
May-01-24 02:45PM
(Investor's Business Daily) +6.25%
Apr-30-24 12:25PM
Apr-29-24 06:11AM
Apr-26-24 03:57PM
11:16AM
07:11AM
(Thomson Reuters StreetEvents)
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Feb 19 '25 Sale 50.10 879 44,034 63,442 Feb 21 05:20 PM Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Feb 20 '25 Sale 50.12 878 44,009 62,564 Feb 21 05:20 PM Gravier Pierre CHIEF FINANCIAL OFFICER Feb 19 '25 Sale 50.10 1,168 58,512 75,603 Feb 21 05:20 PM Gravier Pierre CHIEF FINANCIAL OFFICER Feb 20 '25 Sale 50.12 1,167 58,495 74,436 Feb 21 05:20 PM Pauwels Eric CHIEF EXECUTIVE OFFICER Feb 20 '25 Sale 50.12 1,567 78,544 83,860 Feb 21 05:20 PM Pauwels Eric CHIEF EXECUTIVE OFFICER Feb 19 '25 Sale 50.10 1,378 69,032 85,427 Feb 21 05:20 PM Klein Matthew B. CHIEF EXECUTIVE OFFICER Feb 20 '25 Sale 50.12 3,895 195,233 276,038 Feb 21 05:20 PM Klein Matthew B. CHIEF EXECUTIVE OFFICER Feb 19 '25 Sale 50.10 3,897 195,224 279,933 Feb 21 05:20 PM Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Feb 20 '25 Sale 50.12 962 48,219 76,894 Feb 21 05:20 PM Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Feb 19 '25 Sale 50.10 795 39,826 77,856 Feb 21 05:20 PM Boulding Mark Elliott EXEC. VP AND CLO Feb 20 '25 Sale 50.12 1,614 80,900 103,901 Feb 21 05:20 PM Boulding Mark Elliott EXEC. VP AND CLO Feb 19 '25 Sale 50.10 1,333 66,778 105,515 Feb 21 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Feb 20 '25 Sale 50.12 1,578 79,096 100,353 Feb 21 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Feb 19 '25 Sale 50.10 1,300 65,125 101,931 Feb 21 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Feb 20 '25 Sale 50.12 34 1,704 5,907 Feb 21 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Feb 19 '25 Sale 50.10 34 1,703 5,941 Feb 21 05:20 PM Almstead Neil Gregory Officer Feb 20 '25 Proposed Sale 50.12 1,578 79,096 Feb 20 04:47 PM Almstead Neil Gregory Member of immediate family of Feb 20 '25 Proposed Sale 50.12 34 1,704 Feb 20 04:33 PM Boulding Mark Elliott Officer Feb 20 '25 Proposed Sale 50.12 1,614 80,900 Feb 20 04:32 PM Utter Christine Marie Officer Feb 20 '25 Proposed Sale 50.12 878 44,009 Feb 20 04:21 PM Klein Matthew B. Officer Feb 20 '25 Proposed Sale 50.12 3,895 195,233 Feb 20 04:20 PM Golden Lee Scott Officer Feb 20 '25 Proposed Sale 50.12 962 48,219 Feb 20 04:18 PM Gravier Pierre Officer Feb 20 '25 Proposed Sale 50.12 1,167 58,495 Feb 20 04:17 PM Pauwels Eric Officer Feb 20 '25 Proposed Sale 50.12 1,567 78,544 Feb 20 04:10 PM Almstead Neil Gregory Member of immediate family of Feb 19 '25 Proposed Sale 50.10 34 1,703 Feb 19 04:36 PM Almstead Neil Gregory Officer Feb 19 '25 Proposed Sale 50.10 1,300 65,125 Feb 19 04:34 PM Utter Christine Marie Officer Feb 19 '25 Proposed Sale 50.10 879 44,035 Feb 19 04:27 PM Gravier Pierre Officer Feb 19 '25 Proposed Sale 50.10 1,168 58,513 Feb 19 04:25 PM Boulding Mark Elliott Officer Feb 19 '25 Proposed Sale 50.10 1,333 66,778 Feb 19 04:18 PM Klein Matthew B. Officer Feb 19 '25 Proposed Sale 50.10 3,897 195,226 Feb 19 04:18 PM Golden Lee Scott Officer Feb 19 '25 Proposed Sale 50.10 795 39,827 Feb 19 04:13 PM Pauwels Eric Officer Feb 19 '25 Proposed Sale 50.10 1,378 69,033 Feb 19 04:11 PM Bell William F. Jr. Former Director Feb 03 '25 Proposed Sale 50.00 10,556 527,800 Feb 03 02:14 PM Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Jan 08 '25 Sale 44.50 1,662 73,959 64,321 Jan 10 05:20 PM Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Jan 07 '25 Sale 45.34 1,291 58,534 65,983 Jan 10 05:20 PM Pauwels Eric CHIEF EXECUTIVE OFFICER Jan 08 '25 Sale 44.50 2,136 95,052 86,805 Jan 10 05:20 PM Pauwels Eric CHIEF EXECUTIVE OFFICER Jan 07 '25 Sale 45.34 1,599 72,499 88,941 Jan 10 05:20 PM Klein Matthew B. CHIEF EXECUTIVE OFFICER Jan 08 '25 Sale 44.50 2,402 106,889 283,830 Jan 10 05:20 PM Klein Matthew B. CHIEF EXECUTIVE OFFICER Jan 07 '25 Sale 45.34 2,142 97,118 286,232 Jan 10 05:20 PM Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Jan 08 '25 Sale 44.50 1,198 53,311 78,651 Jan 10 05:20 PM Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Jan 07 '25 Sale 45.34 810 36,725 79,849 Jan 10 05:20 PM Boulding Mark Elliott EXEC. VP AND CLO Jan 08 '25 Sale 44.50 1,998 88,911 106,848 Jan 10 05:20 PM Boulding Mark Elliott EXEC. VP AND CLO Jan 07 '25 Sale 45.34 1,543 69,960 108,846 Jan 10 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Jan 08 '25 Sale 44.50 1,552 69,064 103,231 Jan 10 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Jan 07 '25 Sale 45.34 1,265 57,355 104,783 Jan 10 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Jan 08 '25 Sale 44.50 107 4,762 5,975 Jan 10 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Jan 07 '25 Sale 45.34 55 2,494 6,082 Jan 10 05:20 PM Bell William F. Jr. Former Director Jan 10 '25 Proposed Sale 44.57 6,666 297,104 Jan 10 04:44 PM Almstead Zheng Yang Member of immediate family of Jan 08 '25 Proposed Sale 44.50 107 4,761 Jan 08 05:29 PM Golden Lee Scott Officer Jan 08 '25 Proposed Sale 44.50 1,198 53,311 Jan 08 05:19 PM Almstead Neil Gregory Officer Jan 08 '25 Proposed Sale 44.50 1,552 69,064 Jan 08 05:18 PM Pauwels Eric Officer Jan 08 '25 Proposed Sale 44.50 2,136 95,052 Jan 08 05:06 PM Klein Matthew B. Officer Jan 08 '25 Proposed Sale 44.50 2,402 106,889 Jan 08 05:01 PM Utter Christine Marie Officer Jan 08 '25 Proposed Sale 44.50 1,662 73,959 Jan 08 04:51 PM Boulding Mark Elliott Officer Jan 08 '25 Proposed Sale 44.50 1,998 88,911 Jan 08 04:46 PM Golden Lee Scott Officer Jan 07 '25 Proposed Sale 45.34 810 36,723 Jan 07 04:42 PM Boulding Mark Elliott Officer Jan 07 '25 Proposed Sale 45.34 1,543 69,956 Jan 07 04:38 PM Klein Matthew B. Officer Jan 07 '25 Proposed Sale 45.34 2,142 97,113 Jan 07 04:31 PM Pauwels Eric Officer Jan 07 '25 Proposed Sale 45.34 1,599 72,495 Jan 07 04:31 PM Almstead Neil Gregory Officer Jan 07 '25 Proposed Sale 45.34 1,265 57,352 Jan 07 04:24 PM Almstead Zheng Yang Member of immediate family of Jan 07 '25 Proposed Sale 45.34 55 2,494 Jan 07 04:24 PM Utter Christine Marie Officer Jan 07 '25 Proposed Sale 45.34 1,291 58,531 Jan 07 04:13 PM Klein Matthew B. CHIEF EXECUTIVE OFFICER Dec 31 '24 Sale 45.16 8,279 373,880 217,528 Jan 03 05:21 PM Klein Matthew B. Director Dec 31 '24 Proposed Sale 45.16 8,279 373,876 Dec 31 03:25 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Dec 02 '24 Option Exercise 51.00 69,550 3,547,050 153,158 Dec 04 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Dec 02 '24 Option Exercise 51.00 2,060 105,060 6,636 Dec 04 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Dec 02 '24 Sale 52.06 69,550 3,620,895 86,202 Dec 04 05:20 PM Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Dec 02 '24 Sale 51.97 2,060 107,063 4,576 Dec 04 05:20 PM ZELDIS JEROME B Director Dec 02 '24 Option Exercise 40.93 24,000 982,320 26,500 Dec 04 05:20 PM ZELDIS JEROME B Director Dec 02 '24 Sale 51.50 24,000 1,235,897 14,500 Dec 04 05:20 PM Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Dec 02 '24 Option Exercise 51.00 17,800 907,800 67,123 Dec 04 05:20 PM Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Dec 02 '24 Sale 51.77 17,800 921,585 52,428 Dec 04 05:20 PM Boulding Mark Elliott EXEC. VP AND CLO Dec 02 '24 Option Exercise 51.00 85,600 4,365,600 176,029 Dec 04 05:20 PM Boulding Mark Elliott EXEC. VP AND CLO Dec 03 '24 Option Exercise 33.02 10,308 340,370 100,109 Dec 04 05:20 PM Boulding Mark Elliott EXEC. VP AND CLO Dec 02 '24 Sale 52.26 85,600 4,473,280 92,389 Dec 04 05:20 PM Boulding Mark Elliott EXEC. VP AND CLO Dec 03 '24 Sale 53.26 10,308 549,055 92,389 Dec 04 05:20 PM Boulding Mark Elliott Officer Dec 03 '24 Proposed Sale 53.26 10,308 549,041 Dec 03 04:52 PM Almstead Zheng Yang Member of immediate family of Dec 02 '24 Proposed Sale 51.98 2,060 107,070 Dec 02 05:16 PM Almstead Neil Gregory Officer Dec 02 '24 Proposed Sale 52.06 69,550 3,620,604 Dec 02 04:48 PM Utter Christine Marie Officer Dec 02 '24 Proposed Sale 51.77 17,800 921,544 Dec 02 04:37 PM ZELDIS JEROME B Director Dec 02 '24 Proposed Sale 51.50 24,000 1,235,914 Dec 02 04:31 PM Boulding Mark Elliott Officer Dec 02 '24 Proposed Sale 52.26 85,600 4,473,211 Dec 02 04:26 PM Gravier Pierre CHIEF FINANCIAL OFFICER Jul 16 '24 Sale 34.02 2,269 77,200 53,531 Jul 18 05:20 PM ZELDIS JEROME B Director May 22 '24 Option Exercise 26.42 20,000 528,400 34,500 May 24 05:20 PM ZELDIS JEROME B Director May 22 '24 Sale 38.24 20,000 764,800 14,500 May 24 05:20 PM Golden Lee Scott EVP & CHIEF MEDICAL OFFICER May 07 '24 Sale 32.82 175 5,744 59,813 May 08 05:20 PM Klein Matthew B. CHIEF EXECUTIVE OFFICER Apr 19 '24 Sale 24.89 3,361 83,669 225,807 Apr 22 05:20 PM Pauwels Eric CHIEF EXECUTIVE OFFICER Apr 17 '24 Sale 25.14 787 19,781 67,694 Apr 19 05:20 PM Klein Matthew B. CHIEF EXECUTIVE OFFICER Apr 17 '24 Sale 25.14 1,307 32,851 229,168 Apr 19 05:20 PM Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Apr 02 '24 Sale 28.37 526 14,923 59,988 Apr 04 05:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
